MSD wins two categories and AbbVie another at HR Awards

September 9, 2019 Latest News 'MyBioPharmaSpace'

This is a preview of subscriber content

Subscribe now to continue reading.

The awards, presented in Sydney last Friday at an event attended by over 850 HR professionals, recognise and celebrate the achievements of Australia's HR leaders, companies and teams. …

Subscribe now to continue reading.

Latest Video

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma
November 24, 2025 - Latest News
New national report warns of deepening ovarian cancer burden and calls for urgent action
November 24, 2025 - Latest News
A scrapped website, almost $100 million, and the politics of what really matters
November 23, 2025 - Latest News
NSW Premier opens Australia’s first large-scale health translation hub at UNSW
November 24, 2025 - Latest News
New review recommends a balanced and measured approach to adopting AI in clinical practice
November 24, 2025 - BioPharma

MSD wins two categories and AbbVie another at HR Awards

This is a preview of subscriber content

Latest Video

Most Read

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma

New national report warns of deepening ovarian cancer burden and calls for urgent action

A scrapped website, almost $100 million, and the politics of what really matters

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

New review recommends a balanced and measured approach to adopting AI in clinical practice

New Stories

Slade Pharmacy marks anniversary with record research contributions at conferences

US Medicare sets reimbursement price for PromarkerD, paving way for major commercial rollout

Recce reports strong preclinical efficacy for inhaled R327 in hospital-acquired pneumonia model

Race Oncology secures human ethics approval for lung cancer trial of RC220

Syntara advances next-generation anti-fibrotic cream into Phase 1b trial

AdAlta chair says the company is 'on the cusp' of transformational growth

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer

Sign In

MSD wins two categories and AbbVie another at HR Awards

This is a preview of subscriber content

Latest Video

Most Read

‘Trojan Horse’ treatment offers hope for Australians facing relapsed multiple myeloma

New national report warns of deepening ovarian cancer burden and calls for urgent action

A scrapped website, almost $100 million, and the politics of what really matters

NSW Premier opens Australia’s first large-scale health translation hub at UNSW

New review recommends a balanced and measured approach to adopting AI in clinical practice

Follow Us

New Stories

Slade Pharmacy marks anniversary with record research contributions at conferences

US Medicare sets reimbursement price for PromarkerD, paving way for major commercial rollout

Recce reports strong preclinical efficacy for inhaled R327 in hospital-acquired pneumonia model

Race Oncology secures human ethics approval for lung cancer trial of RC220

Syntara advances next-generation anti-fibrotic cream into Phase 1b trial

AdAlta chair says the company is 'on the cusp' of transformational growth

Scorecard reveals Australia is still ignoring its deadliest and most costly cancer